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The growing frequency of antibiotic resistances is now a universal problem [1]. Antimicrobi-
al resistance occurs through various mechanisms 
such as biofilm formation, enzyme modification 
and efflux pump [2-5]. Increasing resistance to 
new generations of β-lactam and quinolone an-
tibiotics in multidrug-resistant Enterobacteriace-
ae isolates has been considered as an emergen-
cy health issues worldwide [6, 7]. It is believed 
that plasmids act as efficient transporters for the 
spread of antibiotic resistance genes [8, 9].
In the recent decades, due to widespread pre-
scribing of fluoroquinolones, resistance of the 
Enterobacteriaceae to these agents has become 
prevalent. The emergence of plasmid-mediated 
quinolone resistance (PMQR) first was discovered 
in a multi resistant urinary Klebsiella pneumoniae 
isolate, which demonstrated that quinolone re-
sistance can also be acquired through horizontal 
Comparison of quinolone and β-lactam 
resistance among Escherichia coli 
strains isolated from urinary tract 
infections
Zahra Tayebi1, Hamid Heidari2, Hossein Kazemian3,4, Seyed Mohammad Ghafoori1,  
Shahram Boroumandi1,5, Hamidreza Houri6
1Microbiology Department, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran; 
2Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; 
3Department of Medical Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; 
4Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran; 
5Pars Advance and Minimally Invasive Research Center, Pars hospital, Iran University of Medical Sciences,  
Tehran, Iran; 
6Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
The growing frequency of antibiotic resistances is now 
a universal problem. Increasing resistance to new gen-
erations of β-lactam and quinolone antibiotics in multi-
drug-resistant Enterobacteriaceae isolates is considered 
an emergency health issue worldwide. The aim of this 
study was to evaluate plasmid-mediated quinolone re-
sistance genes in ESBL-producing Escherichia coli isolat-
ed from urinary tract infections (UTIs). In our study ES-
BL-producing isolates were assessed by screening meth-
ods. After determination of antimicrobial susceptibility, 
detection of ESBLs and quinolone resistance genes was 
performed. A total of 97 ESBL-producing E. coli were 
determined. The blaTEM, blaSHV and blaCTX-M genes were 
detected in 90 isolates. The blaTEM was the most frequent-
SUMMaRY
ly detected gene (46.4%), followed by blaSHV (31.9%) 
and blaCTX-M (14.4%). The most prevalent quinolone 
resistance gene among ESBL-producing isolates was 
oqxAB which found in 67 isolates (69.1%). The frequen-
cies of the aac(6’)-Ib-cr, qnr and qepA were  65 (67%), 8 
(8.2%) and 6 (6.2%), respectively. Our data indicate that 
the prevalence of plasmid-mediated quinolone resis-
tance genes in ESBL-positive isolates is increasing. The 
co-dissemination of PMQR and ESBL genes among E. 
coli isolates can be considered a threat to public health. 
Therefore, prescription of antibiotics against infectious 
disease should be managed carefully.
Keywords: quinolone, ESBL, E. coli, UTI, Iran.
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gene transmission. The responsible quinolone re-
sistance gene was named qnr [10, 11]. Two addi-
tional mechanisms of PMQR have been described 
including drug modification by acetyltransferase 
AAC(6′)-Ib-cr and active efflux by QepA and Oqx-
AB [12]. 
Escherichia coli is a major cause of nosocomial infec-
tions and represent a serious public health burden 
[13]. Treatment of E. coli infections has been pro-
gressively complicated by the emergence of co-re-
sistance to β-lactams and fluoroquinolones [14]. 
PMQR have been recognized worldwide with a 
quite high prevalence among extended spectrum 
β-lactamases (ESBLs) producing E. coli but there is 
limited comparative information regarding quino-
lone and β-lactam co-resistance in Iran [15].
In the present study, we aimed to assess the inci-
dence of quinolone resistance genes in ESBL-pro-
ducing E. coli isolated from patients with urinary 
tract infections (UTIs).
n MaTERIaLS aND METHODS 
Bacterial isolates
In this cross-sectional study, from January 2013 
to January 2014, 1896 midstream urine specimens 
were collected from inpatients and outpatients, 
suspected of having a bacterial urinary-tract in-
fection (UTI), who had not received antibiotic 
therapy 5-7 days before sampling and referred to 
hospitals of Sari, Iran. Primary isolation of uro-
pathogens was performed by a streak plate tech-
nique on MacConkey agar (Merck Co., Germany) 
and incubation for 24 hours at 37°C. In order to 
identify E. coli, biochemical tests (oxidase, citrate, 
fermentation of glucose, lactose, motility, urease, 
gas and SH2 production) were performed. All 
identified isolates were stored at -80°C in Luria–
Bertani broth (Merck Co., Germany) with 20% 
glycerol.
Antimicrobial susceptibility testing
Antibiotic susceptibility testing was carried out 
by disc diffusion method on Mueller Hinton Agar 
(Merck Co., Germany) according to the Clinical 
Laboratory Standards Institute (CLSI) guidelines 
2015 [16]. The tested antibiotics (Mast Group Ltd., 
Merseyside, UK.) were gentamicin (10 μg), amik-
acin (30 μg), tobramycin (10 μg), ceftriaxone (30 
μg) piperacillin/tazobactam (100/10 μg), nitro-
furantoin (300 μg), cotrimoxazole (1.25/23.75), 
chloramphenicol (30 μg), doxycycline (30 μg), 
meropenem (10 μg) and ciprofloxacin (5 μg).
ESBL-producing isolates were phenotypically 
screened by double-disk synergy test using cefo-
taxime (30 μg) and ceftazidime (30 μg) (Mast Co., 
UK) in the presence and absence of clavulanic 
acid (10 μg). The E. coli ATCC 25922 was used as 
the standard strain.
DNA extraction & gene detection 
The colonies of isolates were suspended in TE 
buffer and their DNA were extracted by boiling 
method. To detection of ESBL responsible genes 
(blaSHV, blaCTX-M and blaTEM), PCR was performed as 
described previously [17].
The ESBL-producing isolates were investigated 
for the presence of oqxAB, qnr, aac(6´)-Ib-cr and 
qepA genes according to previous studies [18,19]. 
Briefly, the PCR mixture was prepared containing 
10 pmol of each primers, 1 μl DNA template (3 
μg/μl), 1.5 mM MgCl2, 0.2 mM each dNTP, and 5 
u Taq DNA polymerase (Cinagen, Iran) in a total 
number of 25 μl of PCR reaction. Amplification of 
oqxAB, qnr, aac(6´)-Ib-cr and qepA genes was per-
formed by this protocol: A predenaturation step 
at 95°C for 5 min, followed by 35 cycles of 60 s at 
95°C, 40 s at 53°C, and 60 s at 72°C. A final exten-
sion step was performed at 72°C for 5 min. PCR 
products electrophoresis was done in 1% agarose 
gels with 0.5X TBE (Tris/Boric acid/EDTA) buf-
fer. DNA bands were seen by staining with KBC 
power load dye (Kawsar Biotech Co. Iran) under 
UV (ultraviolet) illumination.
Statistical analysis
Presence of quinolone resistance genes among 
ESBL positive isolates was calculated by Fisher’s 
exact test for each gene. A p-value of 0.05 was con-
sidered as statistically significant.
n RESULTS 
A total of 225 E. coli strains were isolated from pa-
tients with UTI during 13 months.
Antimicrobial resistance pattern
ESBL production was detected by the screening 
method in 97 of the 225 clinical isolates, repre-
senting 43.1% of the E. coli isolates. Only 2% of 
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the ESBL-producing E. coli isolates showed re-
sistance to meropenem. The antimicrobial resis-
tance rates to other antibiotics were as follows: 
gentamicin (76%), amikacin (17%), tobramycin 
(88%), ceftriaxone (96%) piperacillin/tazobactam 
(4%), nitrofurantoin (9%), cotrimoxazole (80%), 
chloramphenicol (89.6%) and doxycycline (73%). 
Resistance rate to ciprofloxacin was determined 
about 77%.
Distribution of resistance genes
Of 97 ESBL producer strains, blaTEM, blaSHV and 
blaCTX-M genes were detected in 90 isolates. The 
frequencies of blaTEM, blaSHV and blaCTX-M were 
45(46.4%), 31(31.9%) and 14(14.4%), respectively 
(Table 1).
The most prevalent PMQR gene among ES-
BL-producing isolates was oqxAB which found 
in 67 isolates (69.1%). The number of strains har-
boring aac(6’)-Ib-cr, qnr and qepA were 65 (67%), 8 
(8.2%) and 6 (6.2%), respectively. Frequency and 
co-presence of quinolone resistance genes are 
shown in Table 2.
The qnr gene was higher in blaTEM positive isolates 
compared to other isolates significantly (P=0.02). 
Also, co-presence of quinolone and ESBL resis-
tance genes among isolates is mentioned in Table 3.
n DISCUSSION
ESBL-producing E. coli strains have been emerged 
worldwide as an important cause of both com-
munity and hospital acquired UTI [20]. Since ci-
profloxacin is available in oral and intravenous 
preparations, it is ranked as one of the highest 
priority critically important antibiotics against 
UTI caused by E. coli, especially ESBL-producing 
E. coli [21]. However, during the last decade, the 
resistance rate to fluoroquinolones such as cipro-
floxacin has increased and the continuation of this 
trend can have serious clinical consequences [22]. 
In the present study, a high prevalence of PMQR 
determinants was found in the 97 ESBL- produc-
ing E. coli isolates. Over the past ten years, PMQR 
determinants have emerged as an important con-
cern, because they can easily spread among sus-
ceptible bacterial populations [23].
In our study, the prevalence of PMQR genes (oqx-
AB, aac(6’)-Ib-cr, qepA, and qnr) among clinical iso-
lates of ESBL-producing E.coli from patients with 
UTI was investigated. Our findings showed that 
67 clinical isolates of E.coli harbored both of ESBL 
and PMQR genes simultaneously. Surveys on 
the coexistence of PMQR (especially oqxAB) and 
ESBL genes among Enterobacteriaceae have been 
reported in several studies [24-26]. 
Frequency of ESBL-producing strains of E. coli 
vary in different countries. They have been re-
ported at an incidence rate of 43% in Bangladesh, 
while less than 1% of E. coli isolates produce ESBL 
in the European countries [27, 28]. In our evalua-
tions, the combined disc method confirmed ESBL 
production in 97 (43.1%) E. coli isolates, which is 
in agreement with the results of other investiga-
tion in some developing counties [29]. In current 
study, bla genes were not detected in some of iso-
Table 3 - Co-presence of quinolone and ESBL resis-
tance genes among ESBL-producing E. coli.








oqxAB positive 32 (33%) 20 (20.6%) 10 (10.3%)
aac(6’)-Ib-cr positive 26 (26.8%) 23 (23.7%) 9 (9.3%)
qnr positive 7 (7.2%) 1 (1.03%) 2 (2.06%)
qepA positive 4 (4.1%) 1 (1.03%) 1 (1.03%)














TEM & SHV  
& CTX-M
No. (%) 34 (35%) 21 (21.6%) 10 (10.03%) 7 (7.2%) 1 (1.03%) 0 3 (3.1%)















cr & qnr & qep-A
No. (%) 19 (19.5%) 18 (18.5%) 0 0 35 (36%) 4 (4.1%) 0
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lates. It seems that their ESBLs production had 
been related to other β-lactamase encoding genes.
OqxAB is an efflux pump that has a wide sub-
strate specificity including chloramphenicol, 
trimethoprim, and quinolones such as nalidixic 
acid, ciprofloxacin and norfloxacin [11]. The oqx-
AB gene was the most frequent PMQR determi-
nant (69.1%) among ESBL-producing E. coli. This 
result contrasts with reports showing that oqxAB 
gene was found in 0.4% of clinical isolates of E. 
coli in Korea, and 6.6% in China [30, 31]. The high 
levels of prevalence and dissemination of oqxAB 
among UTI isolates may be due to the overuse 
of ciprofloxacin in patients suspected with UTI 
in Iran. Previously, high levels of prevalence of 
oqxAB (60.2%) detected among ESBL-producing 
Klebsiella pneumoniae in Iran [32]. These findings 
suggest that oqxAB genes are conjugative genes 
among ESBL-producing members of Enterobacte-
riaceae family.
The frequencies of the aac(6’)-Ib-cr, qnr and qepA 
genes in urinary tract E. coli isolates in present 
investigation were a similar magnitude to global 
epidemic [33]. aac(6’)-Ib-cr was the second com-
mon PMQR gene in this study. AAC(6’)-Ib-cr, 
an aminoglycoside acetyl- transferase enzyme, 
which is accountable for reduced susceptibility 
to ciprofloxacin by modifying this antibiotic. In 
addition, the aac(6′)-Ib-cr positive clinical isolates 
can indicate resistance to co-trimoxazole [34]. Our 
results indicated that in all of ciprofloxacin and 
co-trimoxazole resistant isolates the aac(6′)-Ib-cr 
gene was found.
We detected 8.2% and 6.1% of isolates harboring 
qepA and qnr, respectively, in accordance with 
another study in West of Iran [35]. The results of 
Sedighi et al. indicated that only 1-2% of uropatho-
genic ESBL-producing E. coli carried qnr genes 
[17]. This difference can be due to the number of 
samples. However, a noticeable increase in strains 
harboring the resistance genes seems possible.
Presence of qnr gene among isolates carrying 
blaTEM was significant and this may be due to 
co-existence of the qnr and blaTEM genes in a com-
mon transmissible plasmid. The co-dissemination 
of PMQR and ESBL genes among E. coli isolates 
can be considered a threat to public health. There-
fore, antimicrobial susceptibility testing is crucial 
in management of UTI cases and antibiotic drugs 
must be prescribed judiciously.
In conclusion, our study indicated that 43.1% of 
isolates were ESBL positive. The blaTEM was the 
most frequently detected ESBL responsible gene. 
The most prevalent plasmid mediated quinolone 
resistance genes among ESBL-producing isolates 
was oqxAB followed by aac(6’)-Ib-cr, qnr and qepA. 
Our data indicated that prevalence of plasmid 
mediated quinolone resistance genes in ESBL pos-
itive isolates is increasing.
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